No Picture
Trading Ideas

Novavax To Commence Australia’s First COVID-19 Vaccine Trial

As part of the urgent global race to tackle the coronavirus outbreak, Novavax (NVAX) is due to commence Phase 1 testing for its SARS-CoV-2 vaccine, NVX-CoV2373, within the coming weeks.According to the statement, this is the third confirmed global Covid-19 vaccine trial and the first in Australia.“The urgent global race to develop a vaccine against the COVID-19 pandemic drove our rapid identification and selection of an optimal, highly immunogenic vaccine candidate,” said Stanley C. Erck, President and CEO of Novavax.The Phase 1 in-human trial of NVX-CoV2373 is expected to begin in mid-May with preliminary immunogenicity and safety results in July, …read more […]

No Picture
Trading Ideas

Abbot Labs Rolls Out Coronavirus Antibody Test, Seeks to Produce 20 Million Tests by June

Abbott Laboratories (ABT) said it is rolling out a laboratory-based blood test which can detect antibodies designed to identify whether someone has had the coronavirus strain Covid-19. The digital device maker is planning to ramp up manufacturing to produce 20 million tests by June.Shares of the healthcare company, which is scheduled to report first-quarter earnings on Thursday, rose 2% to $90.94 a share, while the NYSE Composite Index dropped 2.9%. Analysts expect Abbott to earn an average 58 cents per share in the quarter.The company announced that it expects to ship close to 1 million tests this week to hospitals …read more […]